TScan Therapeutics, Inc. (NASDAQ:TCRX) Shares Sold by Marshall Wace LLP
Marshall Wace LLP cut its holdings in shares of TScan Therapeutics, Inc. (NASDAQ:TCRX – Free Report) by 73.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 43,969 shares of the company’s stock after selling 121,191 shares during the quarter. Marshall Wace LLP owned about […]
